6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
27m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
28m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
51m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
51m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
52m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Hls Therapeutics Inc (TO:HLS) — investor relations, events, news, and company updates on 6ix.

Latest News

HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

HLS Therapeutics Announces Fiscal 2025 Financial Results

HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease

HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call

Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease

Financials

Revenue

CA$55.5 M

Market Cap

CA$137.6 M

EPS

-0.54

Community Chat

Ask AI